ADC Therapeutics (ADCT)
(Delayed Data from NYSE)
$3.33 USD
+0.12 (3.74%)
Updated Sep 20, 2024 04:00 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | -0.38 |
Last EPS Surprise | 13.64% |
ABR | 1.43 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.69 |
Next Year | -1.32 |
EPS (TTM) | -2.55 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 18.72M | 19.57M | 73.76M | 86.38M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 19.27M | 20.10M | 74.27M | 97.34M |
Low Estimate | 18.20M | 18.98M | 73.04M | 80.48M |
Year ago Sales | 14.49M | 16.79M | 69.56M | 73.76M |
Year over Year Growth Est. | 29.19% | 16.54% | 6.04% | 17.11% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | -0.35 | -1.69 | -1.32 |
# of Estimates | 4 | 4 | 5 | 4 |
Most Recent Consensus | -0.36 | -0.38 | -1.85 | -1.53 |
High Estimate | -0.31 | -0.33 | -1.57 | -1.17 |
Low Estimate | -0.36 | -0.38 | -2.04 | -1.53 |
Year ago EPS | -0.58 | -1.03 | -2.94 | -1.69 |
Year over Year Growth Est. | 39.66% | 66.02% | 42.52% | 21.89% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.35 | -0.35 | -1.69 | -1.32 |
7 Days Ago | -0.35 | -0.35 | -1.69 | -1.32 |
30 Days Ago | -0.35 | -0.35 | -1.69 | -1.32 |
60 Days Ago | -0.40 | -0.52 | -1.92 | -1.45 |
90 Days Ago | -0.40 | -0.52 | -1.92 | -1.45 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.35 | -1.69 | -1.32 |
Zacks Consensus Estimate | -0.35 | -0.35 | -1.69 | -1.32 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.38 | -0.56 | -1.03 | -0.58 | NA |
Estimate | -0.44 | -0.56 | -0.47 | -0.61 | NA |
Difference | 0.06 | 0.00 | -0.56 | 0.03 | -0.12 |
Surprise | 13.64% | 0.00% | -119.15% | 4.92% | -25.15% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more